Compliance with osteoporosis drug therapy and risk of fracture

被引：0
作者：
D. Weycker
D. Macarios
J. Edelsberg
G. Oster
机构：
[1] Four Davis Court,Policy Analysis Inc. (PAI)
[2] Amgen,undefined
[3] Inc.,undefined
来源：
Osteoporosis International | 2007年 / 18卷
关键词：
Adherence; Compliance; Fractures; Osteoporosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：271 / 277
页数：6
相关论文
共 50 条
  • [41] Utility of fracture risk calculation by FRAX and Nguyen algorithm for fracture risk assessment and qualification for therapy in Polish women with postmenopausal osteoporosis
    Dytfeld, Joanna
    Marcinkowska, Michalina
    Ignaszak-Szczepaniak, Magdalena
    Gowin, Ewelina
    Michalak, Michal
    Horst-Sikorska, Wanda
    PRZEGLAD MENOPAUZALNY, 2011, 10 (06): : 473 - 479
  • [42] Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study
    Beaudart, Charlotte
    Sharma, Mitali
    Clark, Patricia
    Fujiwara, Saeko
    Adachi, Jonathan D.
    Messina, Osvaldo D.
    Morin, Suzanne N.
    Kohlmeier, Lynn A.
    Sangan, Caroline B.
    Nogues, Xavier
    Cruz-Priego, Griselda Adriana
    Cavallo, Andrea
    Cooper, Fiona
    Grier, Jamie
    Leckie, Carolyn
    Montiel-Ojeda, Diana
    Papaioannou, Alexandra
    Raskin, Nele
    Yurquina, Leonardo
    Wall, Michelle
    Bruyere, Olivier
    Boonen, Annelies
    Dennison, Elaine
    Harvey, Nicholas C.
    Kanis, John A.
    Kaux, Jean-Francois
    Lewiecki, E. Michael
    Lopez-Borbon, Oscar
    Paskins, Zoe
    Reginster, Jean-Yves
    Silverman, Stuart
    Hiligsmann, Mickael
    OSTEOPOROSIS INTERNATIONAL, 2024, 35 (03) : 451 - 468
  • [43] Evaluation of trabecular microarchitecture - Prospects for predicting the risk of osteoporosis and fracture
    Legrand, E
    Chappard, D
    Basle, MF
    Audran, M
    REVUE DU RHUMATISME, 1999, 66 (11): : 543 - 547
  • [44] An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis
    Schini, M.
    Johansson, H.
    Harvey, N. C.
    Lorentzon, M.
    Kanis, J. A.
    McCloskey, E. V.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (03) : 501 - 511
  • [45] An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis
    M. Schini
    H. Johansson
    N. C. Harvey
    M. Lorentzon
    J. A. Kanis
    E. V. McCloskey
    Journal of Endocrinological Investigation, 2024, 47 : 501 - 511
  • [46] Knowledge and compliance towards alendronate therapy among postmenopausal women with osteoporosis in Palestine
    Asma Radwan
    Naser Shraim
    Josephean Elaraj
    Anwar Hamad
    Dana Fatayer
    Bayan Jarar
    Ayoub Johar
    Areen Zriqah
    BMC Women's Health, 22
  • [47] Bone Density Consequences of Initiation and Compliance With Therapy for Osteoporosis
    Yood, Robert A.
    Andrade, Susan E.
    Mazor, Kathleen M.
    Fouayzi, Hassan
    Chan, Wing
    Kahler, Kristijan
    ARTHRITIS CARE & RESEARCH, 2010, 62 (10) : 1440 - 1445
  • [48] Compliance and persistence with osteoporosis medications: A critical review of the literature
    Silverman, Stuart
    Gold, Deborah T.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2010, 11 (04) : 275 - 280
  • [49] Compliance and persistence with osteoporosis medications: A critical review of the literature
    Stuart Silverman
    Deborah T. Gold
    Reviews in Endocrine and Metabolic Disorders, 2010, 11 : 275 - 280
  • [50] Improving the Prediction of Medication Compliance The Example of Bisphosphonates for Osteoporosis
    Curtis, Jeffrey R.
    Xi, Juan
    Westfall, Andrew O.
    Cheng, Hong
    Lyles, Kenneth
    Saag, Kenneth G.
    Delzell, Elizabeth
    MEDICAL CARE, 2009, 47 (03) : 334 - 341
12345